Short Interest in Mayne Pharma Group Limited (OTCMKTS:MAYNF) Increases By 150.5%

Mayne Pharma Group Limited (OTCMKTS:MAYNF) saw a large growth in short interest during the month of May. As of May 15th, there was short interest totaling 162,560 shares, a growth of 150.5% from the April 30th total of 64,905 shares. Based on an average daily volume of 910 shares, the days-to-cover ratio is currently 178.6 days.

Mayne Pharma Group Stock Performance

Shares of Mayne Pharma Group stock remained flat at $1.60 during midday trading on Monday. 40 shares of the company traded hands, compared to its average volume of 3,311. The business has a 50 day simple moving average of $1.68 and a two-hundred day simple moving average of $2.00. Mayne Pharma Group has a 12 month low of $1.40 and a 12 month high of $4.00.

About Mayne Pharma Group

Mayne Pharma Group (OTCMKTS:MAYNF) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of prescription products. The company’s portfolio spans oral, transdermal and topical dosage forms, with a particular emphasis on women’s health, dermatology, pain management and other niche therapeutic areas. Through both branded and generic offerings, Mayne Pharma seeks to address unmet patient needs and provide cost-effective alternatives to established treatments.

In its development operations, Mayne Pharma leverages a combination of in-house research and external partnerships to advance product candidates through regulatory review.